Yahoo
NasdaqGS - Delayed Quote USD

Atrium Therapeutics, Inc. (RNA)

14.19 -0.41 (-2.81%)
At close: September 4 at 4:00:00 PM EDT
14.19 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade RNA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
Total Revenue
35,837
18,618
10,897
9,764
Operating Expense
132,233
95,432
24,115
16,150
Operating Income
-96,396
-76,814
-13,218
-6,386
Other Income Expense
322
-12
2
1
Pretax Income
-93,317
-76,826
-13,216
-6,385
Tax Provision
--
-142
11,906
0
Net Income Common Stockholders
-93,175
-76,684
-25,122
-6,385
Diluted NI Available to Com Stockholders
-93,175
-76,684
-25,122
-6,385
Basic EPS
-5.02
-2.89
-1.47
-0.37
Diluted EPS
-5.02
-2.89
-1.47
-0.37
Basic Average Shares
17,105.64
17,105.64
17,114
17,114
Diluted Average Shares
17,105.64
17,105.64
17,124
17,124
Total Operating Income as Reported
-96,396
-76,814
-13,218
-6,386
Total Expenses
132,233
95,432
24,115
16,150
Net Income from Continuing & Discontinued Operation
-93,175
-76,684
-25,122
-6,385
Normalized Income
-93,175
-76,684
-25,122
-6,385
EBIT
-96,396
-76,814
-13,218
-6,386
EBITDA
-95,711
-76,491
-13,046
-6,248
Reconciled Depreciation
685
323
172
138
Net Income from Continuing Operation Net Minority Interest
-93,175
-76,684
-25,122
-6,385
Normalized EBITDA
-95,711
-76,491
-13,046
-6,248
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2023 - 2/27/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: